Home > Courses > Course Details
Morgenthaler Ventures and the Foundry Course

Morgenthaler Ventures and the Foundry

Hanson Gifford
Robin Bellas
Stanford

Course Description

Lectures

  1. Morgenthaler Ventures Lecture favorites

    Lecture 1 - Morgenthaler Ventures

    Robin Bellas, partner at Morgenthaler Ventures, explains the structure of the venture capital firm.

  2. Advances in Medicine: Surgery Without Knives Lecture favorites

    Lecture 2 - Advances in Medicine: Surgery Without Knives

    Bellas talks about the growing medical trend of surgery without knives and some of the benefits this has.

  3. The Foundry: Background Lecture favorites

    Lecture 3 - The Foundry: Background

    Hanson Gifford, president and CEO of The Foundry, talks about why the company was founded and what they do to help fledgling companies get off the ground and become successful. The incubation process that The Foundry goes through with each new venture helps these companies increase their chances of receiving funding, he says.

  4. Why Does The Foundry Work as an Incubator? Lecture favorites

    Lecture 4 - Why Does The Foundry Work as an Incubator?

    Gifford has found that having The Foundry act as an incubator was the best method possible to help new ventures get started. Over the cycles of incubation, The Foundry becomes familiar with procedures such as the FDA approval process and clinical trial details.

  5. Choosing the Right Medical Devices to Fund Lecture favorites

    Lecture 5 - Choosing the Right Medical Devices to Fund

    The Foundry can only fund a certain number of ventures. Hanson talks about the different factors that go into choosing the companies, including market opportunity, and patient and physician opportunity.

  6. The Unique Relationship Between Morgenthaler and The Foundry Lecture favorites

    Lecture 6 - The Unique Relationship Between Morgenthaler and The Foundry

    While Morgenthaler funds The Foundry, they are also, in essence, funding each new venture that The Foundry incubates. Bellas and Gifford describe the details of this relationship, including the reasons behind establishing it and how they successfully maintain it.

  7. Where Does Innovation Occur? Lecture favorites

    Lecture 7 - Where Does Innovation Occur?

    Bellas talks about where innovation is currently happening in biotech and medical device companies. The large pharmaceutical companies aren't covering the same innovative ground as the smaller companies, which is a trend seeing in every tech field.

  8. Insight Into the Changing Valuations of Companies Since the Dot Com Era Lecture favorites

    Lecture 8 - Insight Into the Changing Valuations of Companies Since the Dot Com Era

    The dot com bubble has changed the way companies are now valued, and their valuations over time. Bellas discusses how valuations are currently determined, and typical financing and return amounts.

  9. Examples of Groundbreaking Achievements in Medicine (Part 1) Lecture favorites

    Lecture 9 - Examples of Groundbreaking Achievements in Medicine (Part 1)

    Bellas talks about two Foundry companies which utilize new surgical procedures. The first is Thermage, which uses a procedure that stimulates new collagen growth. The second is Xstent, which works with stent implants.

  10. Examples of Groundbreaking Achievements in Medicine (Part 2) Lecture favorites

    Lecture 10 - Examples of Groundbreaking Achievements in Medicine (Part 2)

    Gifford discusses some Foundry companies that are showing great success rates, including: Concentric, which treats acute ischemic strokes; Emphasis, with a procedure replacing open-heart surgery with an outpatient procedure, First to File, a non-medical project focusing on intellectual property management; and Satiety, which treats morbid obesity.